DESNI DANTONE: Open Payments
NPI 1861494635 · BEDFORD, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$633 in 38 payments from 14 companies in 2025. Trend: 2023 $610 · 2024 $1,046 · 2025 $633
Food & beverage: $633
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 12 | $139 |
| Novo Nordisk Inc | 5 | $99 |
| Lilly USA, LLC | 4 | $66 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $65 |
| GlaxoSmithKline, LLC. | 2 | $47 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $43 |
| Xeris Pharmaceuticals, Inc. | 2 | $30 |
| Boston Scientific Corporation | 1 | $28 |
| PFIZER INC. | 1 | $24 |
| Indivior Inc. | 1 | $21 |
Products named: VRAYLAR, CAPLYTA, TRELEGY ELLIPTA, MAVYRET, Kerendia, Wegovy, MOUNJARO, WATCHMAN FLX.
Industry payments across PA — which companies pay providers there.
